Scarica l'app Stockscreener
0.6583
11.05%
-0.0818
Dopo l'orario di chiusura:
.66
0.00175
+0.27%
Precedente Chiudi:
$0.74
Aprire:
$0.62
Volume 24 ore:
34,356
Relative Volume:
0.35
Capitalizzazione di mercato:
$1.27M
Reddito:
-
Utile/perdita netta:
$-5.00M
Rapporto P/E:
-0.5724
EPS:
-1.15
Flusso di cassa netto:
$-3.85M
1 W Prestazione:
-49.37%
1M Prestazione:
-60.11%
6M Prestazione:
-80.81%
1 anno Prestazione:
-91.42%
Intervallo 1D:
$0.5401
$0.6583
Intervallo di 1 settimana:
$0.5401
$1.27
Portata 52W:
$0.5401
$14.28
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
Nome
Protagenic Therapeutics Inc
Settore
Industria
Telefono
(212) 994-8200
Indirizzo
149 FIFTH AVENUE, NEW YORK
Confronta PTIX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
0.6583 | 1.43M | 0 | -5.00M | -3.85M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Protagenic Therapeutics Inc Borsa (PTIX) Ultime notizie
How Protagenic Therapeutics Inc. Equity Warrant stock performs in weak economyMarket Growth Review & Real-Time Buy Signal Notifications - ulpravda.ru
Is Protagenic Therapeutics Inc. Equity Warrant stock recession proof2025 Volatility Report & Low Risk Investment Opportunities - ulpravda.ru
Why Protagenic Therapeutics Inc. Equity Warrant stock is a must watch in 2025Dividend Hike & AI Powered Trade Plan Recommendations - ulpravda.ru
Is Protagenic Therapeutics Inc. Equity Warrant stock affected by interest rate hikes2025 Short Interest & Weekly Breakout Watchlists - ulpravda.ru
Is Protagenic Therapeutics Inc. Equity Warrant stock supported by strong cash flowsJuly 2025 Price Swings & Long-Term Safe Return Strategies - ulpravda.ru
Can Protagenic Therapeutics Inc. stock hit analyst price targetsGDP Growth & Long-Term Safe Investment Ideas - ulpravda.ru
How Protagenic Therapeutics Inc. stock trades during market volatilityPortfolio Performance Summary & Weekly Breakout Watchlists - ulpravda.ru
Market Rankings: Is Protagenic Therapeutics Inc. Equity Warrant stock affected by interest rate hikesWeekly Risk Summary & Real-Time Stock Price Movement Reports - ulpravda.ru
Can Protagenic Therapeutics Inc. Equity Warrant stock continue upward trendJuly 2025 Decliners & AI Powered Buy/Sell Recommendations - ulpravda.ru
Protagenic Therapeutics, Inc.(NasdaqCM: PTIX) dropped from S&P TMI Index - MarketScreener
How Protagenic Therapeutics Inc. stock performs in high volatility markets2026 world cup usa national team group stage playmakers possession football winner prediction insights - ulpravda.ru
Protagenic Therapeutics to begin OTC trading after Nasdaq delisting - Investing.com
Protagenic Therapeutics Prepares for Nasdaq Delisting, OTC Trading - TipRanks
Protagenic Therapeutics to begin OTC trading after Nasdaq delisting By Investing.com - Investing.com India
Protagenic Therapeutics Received Notice of Delisting - TradingView — Track All Markets
Protagenic Therapeutics Inc. (PTIX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice - Livingston Daily
Support Test: Is Protagenic Therapeutics Inc Equity Warrant stock affected by interest rate hikes2025 Trade Ideas & AI Driven Price Forecasts - moha.gov.vn
Protagenic Therapeutics receives Nasdaq non-compliance letter - MSN
EPS Watch: Is Protagenic Therapeutics Inc stock a buy on dips2025 Trade Ideas & Safe Capital Growth Plans - moha.gov.vn
ETF Watch: Is Protagenic Therapeutics Inc. Equity Warrant stock supported by strong fundamentalsQuarterly Portfolio Summary & Verified High Yield Trade Plans - moha.gov.vn
Is Protagenic Therapeutics Inc. Equity Warrant stock attractive for income investorsQuarterly Growth Report & Expert Curated Trade Ideas - Улправда
Will Protagenic Therapeutics Inc. stock deliver shareholder valueJuly 2025 Breakouts & Verified Momentum Watchlists - Улправда
Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th - Newswire.com
Can Protagenic Therapeutics Inc. stock hit record highs againMarket Trend Summary & Capital Efficient Trade Techniques - Улправда
Published on: 2025-12-20 04:38:52 - Улправда
Why Protagenic Therapeutics Inc. stock remains undervalued2025 Volatility Report & Low Risk Profit Maximizing Plans - Улправда
Published on: 2025-12-19 23:10:33 - Улправда
Published on: 2025-12-19 21:59:06 - Улправда
Risk Hedge: Is Protagenic Therapeutics Inc. Equity Warrant stock supported by strong fundamentalsWeekly Investment Report & Stepwise Entry/Exit Trade Alerts - Улправда
Will Protagenic Therapeutics Inc. stock reach all time highs in 2025Earnings Growth Summary & Risk Managed Trade Strategies - DonanımHaber
Will Protagenic Therapeutics Inc. stock split attract more investors2025 Investor Takeaways & Reliable Price Breakout Signals - DonanımHaber
Will Protagenic Therapeutics Inc. stock benefit from commodity pricesMarket Volume Summary & Technical Buy Zone Confirmation - Улправда
Can Protagenic Therapeutics Inc. stock maintain growth trajectoryMarket Activity Recap & Safe Entry Trade Signal Reports - Улправда
Resistance Check: Can Protagenic Therapeutics Inc. stock maintain growth trajectoryJuly 2025 Pullbacks & Accurate Buy Signal Alerts - Улправда
Can Protagenic Therapeutics Inc. stock attract ESG capital inflowsWeekly Profit Summary & Stock Portfolio Risk Control - Улправда
Gap Down: Can Protagenic Therapeutics Inc. stock maintain growth trajectoryQuarterly Trade Review & Growth-Oriented Investment Plans - Улправда
Published on: 2025-12-18 16:25:19 - Улправда
Protagenic Therapeutics Inc (PTIX) - MSN
What analysts say about Protagenic Therapeutics Inc stockValue Stock Picks & Rapid Capital Gain - earlytimes.in
Protagenic reports results from phase 1 multiple-dose study of PT00114 - MSN
Taking on analysts’ expectations and winning: Protagenic Therapeutics Inc (PTIX) - setenews.com
Protagenic Therapeutics (PTIX) Shares Phase 1 Study Results for PT00114 - GuruFocus
Protagenic reports positive safety results for stress disorder drug By Investing.com - Investing.com Canada
Protagenic reports positive safety results for stress disorder drug - Investing.com
Results from Phase 1 Multiple-Dose Study of PT00114 - ACCESS Newswire
Protagenic Therapeutics (NASDAQ: PTIX) reports positive Phase 1 multiple-dose safety data for PT00114 - Stock Titan
What Makes Kalyan Jewellers India Limited Stand Out Among CompetitorsSupport and Resistance Levels & Minimal Investment Portfolio - earlytimes.in
Will Protagenic Therapeutics Inc. (MBP0) stock profit from automation waveWeekly Trade Recap & Pattern Based Trade Signal System - Newser
Is Protagenic Therapeutics Inc. (MBP0) stock a buy before new product rollout2025 Support & Resistance & Daily Profit Focused Stock Screening - Newser
Will Protagenic Therapeutics Inc. (MBP0) stock enhance shareholder valueJuly 2025 Fed Impact & Scalable Portfolio Growth Methods - Newser
Protagenic Therapeutics Inc Azioni (PTIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):